Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Endoprosthetic Replacement for Pathological Fractures of the Hip: A 35-year Update

NCT06935071 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.

NCT NCT06935071
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06935071 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Endoprosthetic Replacement for Pathological Fractures of the Hip: A 35-year Update
Lead sponsor
Memorial Sloan Kettering Cancer Center
Phase
Observational
Overall status
Active, not recruiting
Start date
August 4, 2016
Completion date
August 4, 2027
Enrollment
300 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hip fracture pathologic, hip fractures, pathological fracture, pathological fracture of hip